Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial

BACKGROUND: We investigated safety and immunogenicity of 1–2 doses of different bivalent virus-like particle (VLP) norovirus vaccine candidate (NoV) formulations in healthy 18- to 64-year-olds. METHODS: On days 1 and 28, participants (n = 420) randomized to 14 equal groups received intramuscular con...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Dis
Autors principals: Leroux-Roels, Geert, Cramer, Jakob P, Mendelman, Paul M, Sherwood, James, Clemens, Ralf, Aerssens, Annelies, De Coster, Ilse, Borkowski, Astrid, Baehner, Frank, Van Damme, Pierre
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Major Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5853300/
https://ncbi.nlm.nih.gov/pubmed/29140444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix572
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars